AF488 Anti-Human CD44 Antibody[Hermes-1]

AF488 Anti-Human CD44 Antibody[Hermes-1]

Introducing the AF488 Anti-Human CD44 Antibody [HERMES-1], a highly advanced and meticulously developed product designed to cater to the specific needs of the scientific community. This antibody, labeled with AF488, offers exceptional specificity and sensitivity in detecting the CD44 antigen in human samples.

The AF488 Anti-Human CD44 Antibody [HERMES-1] is meticulously engineered using cutting-edge technology and rigorous quality control measures to ensure optimal performance and reliability. Its unique formulation guarantees accurate and reproducible results, making it an indispensable tool for various research applications.

This antibody is specifically designed to target the CD44 antigen, a cell surface glycoprotein involved in numerous physiological and pathological processes. With its exceptional affinity and selectivity, the AF488 Anti-Human CD44 Antibody [HERMES-1] enables precise identification and characterization of CD44-expressing cells in human samples.

The AF488 labeling of this antibody provides an additional advantage, as it allows for direct visualization and quantification of CD44 expression using fluorescence microscopy or flow cytometry. This feature enhances the versatility and convenience of this product, facilitating a wide range of experimental techniques and applications.

Furthermore, the AF488 Anti-Human CD44 Antibody [HERMES-1] exhibits excellent stability and minimal non-specific binding, ensuring reliable and reproducible results even in challenging experimental conditions. Its exceptional performance and reliability make it an ideal choice for researchers seeking accurate and robust detection of CD44 in human samples.

In summary, the AF488 Anti-Human CD44 Antibody [HERMES-1] is a highly advanced and reliable tool for the precise detection and characterization of CD44-expressing cells in human samples. With its exceptional specificity, sensitivity, and versatility, this antibody is an invaluable asset for researchers in various fields, including immunology, oncology, and regenerative medicine.